Ocean Biomedical Receives Notice From Nasdaq That It Is Not In Compliance With Listing Rule
Portfolio Pulse from Benzinga Newsdesk
Ocean Biomedical has received a notice from Nasdaq indicating non-compliance with listing rules due to delays in filing its Form 10-Q, following previously disclosed issues with its 10-K filing for the year ended December 31, 2023.
May 30, 2024 | 11:46 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ocean Biomedical is facing non-compliance issues with Nasdaq due to delays in filing its Form 10-Q, which follows earlier problems with its 10-K filing.
The notice from Nasdaq regarding non-compliance due to delayed filings is likely to negatively impact investor sentiment and the stock price of Ocean Biomedical in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100